We are live on ! Find out more
BL

Bleichroeder LP Portfolio holdings

AUM $559M Turnover 17.24%
1-Year Est. Return 83.7%
This Fund
S&P 500
This Quarter Est. Return
+27%
1 Year Est. Return
+83.7%
3 Year Est. Return
+202.15%
5 Year Est. Return
+208.71%
10 Year Est. Return
–
AUM
$568M
AUM Growth
+$55.3M
Cap. Flow
+$7.09M
Cap. Flow %
1.25%
Top 10 Hldgs %
82.48%
Holding
77
New
5
Increased
9
Reduced
4
Closed
4
Avg Time Held
2.9 years
Top 10 Avg Time Held
2.1 years
Top 20 Avg Time Held
2.5 years

Top Buys

Rank Stock Value
1
KZIA icon
Kazia Therapeutics
KZIA
+$3.41M
2
DTIL icon
Precision BioSciences
DTIL
+$3.33M
3
PXLW icon
Pixelworks
PXLW
+$1.54M
4
GPGI icon
GPGI Inc
GPGI
+$1.1M
5
EYPT icon
EyePoint Inc
EYPT
+$850K

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$3M
2
CMPOW icon
CompoSecure Inc Warrant
CMPOW
+$1.28M
3
FEAM icon
5E Advanced Materials
FEAM
+$997K
4
EVOK icon
Evoke Pharma
EVOK
+$728K
5
GPCR icon
Structure Therapeutics
GPCR
+$408K

Sector Composition

Rank Sector Weight
1 Miscellaneous 37.76%
2 Industrials 28.25%
3 Healthcare 13.73%
4 Technology 6.13%
5 Materials 5.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
EVOK icon
76
DELISTED
Evoke Pharma
EVOK
– –
-146,395
Closed -$728K –
FEAM icon
77
5E Advanced Materials
FEAM
$132M
– –
-285,714
Closed -$997K –
1 2 3
4

Similar funds

NFW
Noble Family Wealth Clearwater, Florida $559M AUM 24.35% 1-Year Est. Return
SCM
Soros Capital Management New York $559M AUM 171.77% 1-Year Est. Return
PHC
Palidye Holdings (Caymans) Grand Cayman, Cayman Islands $559M AUM 1.08% 1-Year Est. Return
EPM
Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return
BCM
Brasada Capital Management Houston, Texas $558M AUM 21.68% 1-Year Est. Return
FAM
Frontier Asset Management Sheridan, Wyoming $558M AUM 22.41% 1-Year Est. Return
WDG
Wealth Dimensions Group Cincinnati, Ohio $558M AUM 20.63% 1-Year Est. Return
OC
Opal Capital Boca Raton, Florida $560M AUM

Bleichroeder LP's Q4 2025 Portfolio in Review

As of Q4 2025, Bleichroeder LP held 77 positions worth $568M, up 11% from $513M the previous quarter. Its ten largest holdings account for 82% of the portfolio.

Bleichroeder LP's Q4 2025 filing shows 5 new, 9 increased, 4 reduced and 4 closed positions. Its largest new stake was Kazia Therapeutics: 400,000 shares worth $2.76M. The largest sale was Linde, an estimated $3M.

By sector, the portfolio is most concentrated in Miscellaneous at 38% of assets, down from 38% a quarter earlier, followed by Industrials and Healthcare.

  • Bleichroeder LP's largest Q4 2025 buy was Kazia Therapeutics: 400,000 shares worth $2.76M.
  • Bleichroeder LP added most to Precision BioSciences in Q4 2025, an estimated $3.33M increase.
  • Bleichroeder LP's biggest Q4 2025 reduction was Linde, cutting an estimated $3M.
  • Bleichroeder LP fully exited CompoSecure Inc Warrant in Q4 2025, selling an estimated $1.28M.
  • Bleichroeder LP's ten largest holdings make up 82% of its $568M portfolio in Q4 2025.
  • Bleichroeder LP opened 5 new positions and closed 4 in Q4 2025.
  • Bleichroeder LP's portfolio value rose 11% quarter-over-quarter to $568M.

Based on Bleichroeder LP's 13F filing for Q4 2025, filed 13 Feb 2026.